Abstract Library

#1876 Multiple Endocrine Neoplasia Type 1 (MEN1): The Experience of a Referral Center in Greece

Introduction: Multiple endocrine neoplasia type 1 (MEN1) is a genetic disorder involving mainly parathyroid, pituitary and pancreatic neuroendocrine neoplasms (pNENs)

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Alexandraki K, Chrysochoou M, Kaltsatou M, Tsoli M, Nikolopoulos G,

Keywords: MEN1,

#1402 Merkel Cell Carcinoma of Lymph Node Without Skin Primary Can - and Should - Be Distinguished from Others Metastatic Neuroendocrine Carcinoma

Introduction: Merkel cell carcinoma of lymph node without primary tumour (MCCNWP) is a rare tumour which can be misinterpreted as lymph node metastasis (LNM) from a high-grade neuroendocrine carcinoma (NEC) on histological examination. However, this distinction is crucial for therapeutic management.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: KERVARREC T

Authors: Kervarrec T, Samimi M, Beby-Defaux A, Touze A, Guyetant S,

Keywords: Merkel cell carcinoma, lymph node, MCPyV,

#1252 Radio-chemotherapy versus Surgery in Non-metastatic Ano-rectal Neuroendocrine Carcinoma: A Multicenter Study by the Association des Gastro-Entérologues Oncologues

Introduction: Neuroendocrine carcinomas (NEC) of the anus or the rectum are a rare disease, accounting for less than 1% of all digestive malignancies. Most are metastatic at diagnosis and treated with a platinum-based chemotherapy. No guidelines for localized tumors exist.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Coriat R

Authors: Brieau B, Lepère C, Walter T, Lecomte T, Guimbaud R,

Keywords: Neuroendocrine carcinoma, ano-rectal tumor, surgery, radio-chemotherapy,

#868 Role of 68Ga-DOTATATE PET/TC (68Ga-PET-CT) for the Management of Patients with Neuroendrocrine Tumors (NETs): Impact in Therapeutic Decisions of our Clinical Practice

Introduction: 68Ga-PET-CT has demonstrated a higher diagnostic accuracy than any other imaging procedures (CT/MRI/SRS). ARGENTUM group described their experience with 68Ga-PET-CT in eight patients with advanced Gastroenteropancreatic Neuroendocrine Tumors (ENETS 2011). Conclusion was that 68Ga-PET-CT enabled changes in the strategy of treatment in all cases. The impact of 68Ga-PET-CT on the therapeutic management in NETs is constantly under evaluation.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: Castillo Mandon A

Authors: Pesce V, Castillo Mandon A, O'Connor J, Bestanti C, Eleta M,

Keywords: neuroendocrine tumors, 68ga-pet-ct, therapeutic management,